958 filings
Page 35 of 48
424B5
HALO
Halozyme Therapeutics, Inc.
5 Feb 14
Prospectus supplement for primary offering
12:00am
424B5
HALO
Halozyme Therapeutics, Inc.
3 Feb 14
Prospectus supplement for primary offering
12:00am
SC 13G
BLK
BlackRock, Inc.
29 Jan 14
Halozyme Therapeutics Inc
12:00am
CORRESP
HALO
Halozyme Therapeutics, Inc.
17 Jan 14
Correspondence with SEC
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
13 Jan 14
Regulation FD Disclosure
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
3 Jan 14
Entry into a Material Definitive Agreement
12:00am
CT ORDER
HALO
Halozyme Therapeutics, Inc.
31 Dec 13
Confidential treatment order
12:00am
CORRESP
HALO
Halozyme Therapeutics, Inc.
26 Dec 13
Correspondence with SEC
12:00am
UPLOAD
HALO
Halozyme Therapeutics, Inc.
20 Dec 13
Letter from SEC
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
18 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
8 Nov 13
Results of Operations and Financial Condition
12:00am
10-Q
2013 Q3
HALO
Halozyme Therapeutics, Inc.
Quarterly report
8 Nov 13
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
31 Oct 13
Regulation FD Disclosure
12:00am
SC 13G
BBBOF
BB Biotech Ag
14 Aug 13
Halozyme Therapeutics Inc
12:00am
10-Q
2013 Q2
HALO
Halozyme Therapeutics, Inc.
Quarterly report
7 Aug 13
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
7 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
3 Jul 13
Other Events
12:00am
S-8
HALO
Halozyme Therapeutics, Inc.
31 May 13
Registration of securities for employees
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
24 May 13
Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
12:00am
8-K
HALO
Halozyme Therapeutics, Inc.
17 May 13
Departure of Directors or Certain Officers
12:00am